文献速递肿瘤 PET/CT核素与放射性配体治疗

化疗改变前列腺癌与乳腺癌细胞的放射敏感性和GRPR表达

Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells.
PubMed 文献 · EJNMMI Res · 2025-08-01

本研究在前列腺癌(PCa)与乳腺癌(BC)细胞中探讨多柔比星(DXR)和多西他赛(DTX)对GRPR表达、GRPR放射性示踪剂摄取及对外照射放疗(EBRT)和靶向放射性核素治疗反应的影响,并在PC-3与T47D异种移植小鼠中用SPECT/CT评估「NeoB」的体内摄取。结果显示DTX显著降低PC-3细胞的GRPR表达、示踪剂摄取和放射敏感性;DXR预处理的T47D细胞GRPR表达和示踪剂摄取增加且对EBRT较不敏感。结论认为化疗在体外改变与GRPR介导放射性核素治疗成功相关的机制,这些发现在体内较不明显,需进一步研究阐明。

要点

  • DTX显著降低PC-3细胞的GRPR表达、放射性示踪剂摄取和放射敏感性。
  • DXR预处理的T47D细胞GRPR表达和示踪剂摄取增加,且对EBRT较不敏感。
  • 体内DTX预处理增加PC-3异种移植瘤对[177Lu]Lu-NeoB的摄取,但非GRPR介导。

核心结论

  • 数据表明化疗在体外改变与前列腺癌和乳腺癌细胞中GRPR介导放射性核素治疗成功相关的机制。
  • 这些发现在体内较不明显,需进一步研究阐明。

研究设计与样本

  • 体外研究:在前列腺癌(PCa)和乳腺癌(BC)细胞中研究多柔比星(DXR)和多西他赛(DTX)对GRPR表达、GRPR放射性示踪剂摄取及对外照射放疗(EBRT)和靶向放射性核素治疗反应的影响。
  • 体内研究:在PC-3和T47D异种移植荷瘤小鼠中,化疗后用SPECT/CT评估GRPR靶向放射性示踪剂「NeoB」的体内摄取。

主要发现

  • DTX显著降低PC-3细胞体外GRPR表达、放射性示踪剂摄取和放射敏感性。
  • DXR预处理的T47D细胞GRPR表达和放射性示踪剂摄取增加,且对EBRT较不敏感。
  • 体内DTX预处理增加PC-3异种移植瘤对[177Lu]Lu-NeoB的摄取,但非GRPR介导。
  • DXR预处理未改变T47D异种移植瘤对[177Lu]Lu-NeoB的摄取,但观察到GRPR mRNA表达增加。

局限性

  • 这些发现在体内较不明显,需进一步研究阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastrin releasing peptide receptor (GRPR)-targeting radiotracers have been studied (pre)-clinically with promising results. Patients eligible for this treatment are likely to have undergone prior treatments with other anti-cancer agents, including chemotherapy. Chemotherapies are known to alter cancer cell's gene expression and radiosensitivity, potentially impacting GRPR expression and the response to radionuclide therapy. We studied the effect of two commonly applied chemotherapies, doxorubicin (DXR) and docetaxel (DTX), on GRPR expression, GRPR radiotracer uptake, and response to external beam radiation therapy (EBRT) and targeted radionuclide treatment, in prostate cancer (PCa) and breast cancer (BC) cells. Additionally, in-vivo uptake of the GRPR-targeting radiotracer "NeoB" in PC-3 and T47D xenograft-bearing mice was assessed using SPECT/CT following chemotherapy treatment. RESULTS: DTX significantly decreased GRPR expression, radiotracer uptake, and radiosensitivity of PC-3 cells in-vitro. DXR pre-treated T47D cells demonstrated an increased GRPR expression and radiotracer uptake, and were less sensitive to EBRT. In-vivo, DTX pre-treatment increased [177Lu]Lu-NeoB uptake in PC-3 xenografts, but this was not GRPR mediated. DXR pre-treatment did not alter [177Lu]Lu-NeoB uptake in T47D xenografts, but an increase in GRPR mRNA expression was observed. CONCLUSION: Our data demonstrated that chemotherapy alters mechanisms relevant for the success of GRPR-mediated radionuclide therapy in PCa and BC cells in-vitro. These finding were less prominent in-vivo and additional studies are needed to unravel this.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Damiana TST, van den Brink L, de Kreij-de Bruin LW, et al. Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells. EJNMMI Res. 2025. PMID: 40751101. doi:10.1186/s13550-025-01302-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。